Zdrowie i gospodarka · 22/11/2004

FDA Announces Guidance on Changes to Approved Drug Applications

The Food and Drug Administration (FDA) has released a guidance document outlining its plan to use enforcement discretion for certain changes to approved new drug applications (NDAs) and abbreviated new drug applications (ANDAs), allowing manufacturers to submit such changes in their annual reports instead of a 30-day supplement.